Szeged University   Report issue

Academic/Hospital Phase 3
Founded: Szeged Hungary (1872)

Organization Overview

First Clinical Trial
2010
NCT02337010
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Affidea Magyarország | Institute of Surgical Research, University of Szeged | István Kósa | Szeged University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 8